ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Xultophy®:Novo Nordisk Pharma AG
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
A10AE56 - Insulin Degludec and LiraglutideATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A10 - Drugs Used in Diabetes
 
A10A - Insulins and Analogues

This group comprises both human - and animal insulins.
Insulin preparations are classified at 4 different 4th levels, according to onset and duration of action. Each 4th level is differentiated in 5th levels according to origin of insulin.
Products consisting of, e.g. beef and pork insulin, are classified as combinations (30-levels) at each 4th level according to onset and duration of action.

The DDD for insulins is 40 units.

A10AE - Insulins and Analogues for Injection, Long-Acting
 
A10AE56 - Insulin Degludec and Liraglutide
Concentr.Adm.RouteNote
40 UPRefers to insulin degludec
2020 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home